With fakes of the cancer drug Avastin popping up in U.S. clinics in the past few months, patients are naturally worried about whether their medicines are safe.  Considering eighty percent of the ingredients in U.S. medicines come from overseas – mostly from China and India because their products are generally...

Will more regulations and a more centralized food safety bureaucracy make us safer? What kind of regulations and implementation mechanisms would best serve the public's desire for ensuring food safety?

Why doesBeijing have so much troublestopping the exportation of dangerous drugs?

The Food and Drug Administration's letter to Cheerios typifies the FDA's longstanding discomfort with health claims made on food labels, particularly those touting the medical benefits of certain diets and ingredients.

Mindless cuts that are utterly penny-wise and pound-foolish show how distorted our deliberative process has become. In the headlong rush to provide a better fiscal future for our children, we should not be providing a less safe present for all of us.

The U.S. is not immune to lethal failings in the quality of pharmaceutical drugs. With little realistic oversight, and more importantly, little ethos of business integrity in China, a major tragedy in the U.S. from a Chinese export is likely in the near future.

This is an all too familiar story, the FDA impeding useful innovations in the US entrepreneurs here are forced to test promising medical devices in costly animal studies for years before they can advance their products into clinical trials. In response, American device makers are moving their business overseas.

What impact does the Centers for Medicare & Medicaid Services drug coverage have on the future of biologic products?